首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   3106篇
  免费   47篇
  国内免费   2篇
电工技术   45篇
综合类   8篇
化学工业   337篇
金属工艺   58篇
机械仪表   43篇
建筑科学   35篇
矿业工程   8篇
能源动力   37篇
轻工业   166篇
水利工程   10篇
石油天然气   4篇
无线电   237篇
一般工业技术   379篇
冶金工业   1491篇
原子能技术   48篇
自动化技术   249篇
  2023年   13篇
  2022年   26篇
  2021年   34篇
  2020年   17篇
  2019年   17篇
  2018年   19篇
  2017年   20篇
  2016年   41篇
  2015年   26篇
  2014年   40篇
  2013年   103篇
  2012年   74篇
  2011年   98篇
  2010年   85篇
  2009年   73篇
  2008年   72篇
  2007年   73篇
  2006年   53篇
  2005年   62篇
  2004年   59篇
  2003年   44篇
  2002年   49篇
  2001年   42篇
  2000年   29篇
  1999年   75篇
  1998年   461篇
  1997年   247篇
  1996年   207篇
  1995年   127篇
  1994年   85篇
  1993年   96篇
  1992年   37篇
  1991年   45篇
  1990年   50篇
  1989年   50篇
  1988年   41篇
  1987年   26篇
  1986年   28篇
  1985年   38篇
  1984年   21篇
  1983年   14篇
  1982年   20篇
  1981年   19篇
  1980年   25篇
  1978年   18篇
  1977年   32篇
  1976年   94篇
  1975年   12篇
  1974年   13篇
  1973年   18篇
排序方式: 共有3155条查询结果,搜索用时 15 毫秒
31.
32.
Several in vitro and in vivo studies indicate that application of high doses of dominant T cell epitopes can induce a state of antigen-specific non-responsiveness (anergy). In the present study, we developed a murine model of an allergic immune response to Bet v 1, the major birch pollen allergen. Mice were sensitized by injection of rBet v 1 and the allergic state was proven by the presence of allergen-specific IgE and positive immediate-type skin tests to Bet v 1. In epitope mapping experiments, an immunodominant T cell epitope of Bet v 1 in BALB/c mice was identified by the use of overlapping peptides. This peptide (BV 139) was subsequently employed for treatment. Two tolerization protocols were used: in one approach, the peptide was administered to naive mice before immunization (group BV139-S), in the second, already sensitized mice were treated (S-BV139). The results demonstrated that administering high doses of the dominant T cell epitope of Bet v 1 profoundly diminished T cell proliferation to the peptide in the BV139-S group, and to the peptide as well as to the whole protein in the S-BV139 group. Skin test reactivity to Bet v 1 was reduced in the BV139-S group. However, no differences in terms of specific antibody production between treated and untreated mice could be observed. This study provides evidence that administration of dominant T cell epitopes can down-regulate the allergen-specific T cell response. Proceeding on the assumption that the T lymphocyte response to allergens is crucial for the induction and maintenance of the allergic disease, a modulation of the immune response to allergens by treatment with T cell epitope peptides could represent a promising concept for immunotherapy in the future.  相似文献   
33.
Formal program construction by transformations is a method of software development in which a program is derived from a formal problem specification by manageable, controlled transformation steps which guarantee that the final product meets the initial specification. This methodology has been investigated in the Munich project CIP (computer-aided intuition-guided programming). The research includes the design of a wide-spectrum language specifically tailored to the needs of transformational programming, the construction of a transformation system to support the methodology, and the study of transformation rules and other methodological issues. Particular emphasis has been laid on developing a sound theoretical basis for the overall approach  相似文献   
34.
Interferon-gamma (IFN-gamma) has the most potent immunomodulatory activity of all the interferons. This phase II-B study was performed to define time- and dose-dependent immunomodulatory effects mediated by IFN-gamma in a subset of patients with melanoma treated in the dose-seeking therapeutic trial conducted by the Eastern Cooperative Oncology Group E4687 (13). The effects of IFN-gamma (Genentech, San Francisco, CA) were evaluated for phenotype and function of peripheral blood lymphocytes obtained twice prestudy, and on days 2, 9, and 29 of IFN-gamma therapy for 50 patients. Early significant increases in CD4/CD8 ratio (p = 0.001) were noted, largely due to a rise in CD4+ and fall in CD8+ T-cell populations sustained through day 29 at only the lowest dosage. Increased natural killer cell (NK) activity (p = 0.001 on day 9; p = 0.01 on day 29) was accompanied by durable increases in circulating activated NK cells (CD56+DR+% p = 0.001, day 9; p = 0.001, day 29). After initial depression of CD56+ and CD16+ cells on day 2, the total percent of CD56+ and CD16+ cells increased significantly by day 29. Increases in NK cell activity were maximal at doses > or =0.1 mg. Monocyte CD14+ expression of DQ+ rose early (p = 0.011 and 0.001 on days 2 and 9), accompanied by elevation in CD14+DR+ cells that was less significant. Immunomodulatory effects of IFN-gamma reported in this trial have major implications for interpretation of past and current clinical trials, and the design of future trials. This is the first trial in which IFN-gamma has been shown to have significant effects on the T-cell compartment of the immune system.  相似文献   
35.
The response due to time-fluctuating temperature distribution applied at the free surface of a viscoelastic cylindrical liquid column with no axial dependency has been determined analytically. The amplitude of the radial- and angular velocity as well as the free liquid surface elevation has been presented as a function of the “reduced” forcing frequency of the oscillatory temperature and has numerically been evaluated for an angular temperature field proportional to sin 2φ. It was found, that visco-elasticity as described by the Maxwell model has quite some influence upon the liquid behavior. It shows for larger relaxation times besides the enlarged resonance peak additional peaks below and above resonance. This is particularly evident inside the liquid column, indicating a more pronounced elastic behavior of the liquid.  相似文献   
36.
In most countries of the world asphalt pavement of road networks represents the biggest single investment in the transportation system. In Canada, asphalt pavement built over the past decade is worth more than 70 billion dollars (in 1984 dollars). In order to maintain the current road network at the present level of service and prevent it from further deterioration, over 6 billion dollars is needed anually.

Traditionally, asphalt overlays are widely used to rehabilitate existing deteriorated pavements. Unfortunately the new overlays have been observed to fail in a relatively short time. Thus the investment in overlays is lost.

Recent research based on the concept of relative rigidity has indicated that the rapid deterioration of new asphalt overlays is directly related to current construction equipment. It has been shown analytically and experimentally that steel rollers used in compacting the asphalt layer will result in surface cracks during construction. Traffic and environmental influences will accelerate the failure of the new layer.

This paper presents the results of a testing programme evaluating the engineering properties of asphalt slabs compacted by a new method using a compactor termed AMIR. The results showed that the AMIR compactor will prevent the formation of constitution cracks resulting in an increase of indirect tensile strength of 10% and an increase of direct tensile strength of up to 60% when compared to steel roller compacted asphalt slabs.  相似文献   

37.
An analytical procedure was developed in which thirteen herbicides (10 acidic and 3 neutral compounds) may be extracted from drinking water samples using solid phase extraction disks and subsequently analyzed by gas chromatography-mass spectrometry. Using 8 replicate samples consisting of reagent water fortified with nanogram quantities of each herbicide, the average percent recoveries and method detection limits were determined for each analyte. The method was found to be suitable for the determination of individual herbicides in drinking water at concentrations of approximately 10 ng/L.  相似文献   
38.
The purpose of our study was to determine the prevalence of sleep related breathing disorders (SRBD) in patients with an implantable cardioverter-defibrillator (ICD) and to evaluate prospectively the possible influence of SRBD on arrhythmia recurrence and circadian arrhythmia variation as well as on cardiac mortality during long-term follow-up. Forty consecutive ICD recipients with cardiac disease and a documented history of spontaneous, life-threatening, ventricular tachyarrhythmias underwent full-night polysomnography and were followed for 2 years. In 16 of 40 patients (40%), SRBD were diagnosed (Apnea/Hypopnea Index (AHI) > 10); in 9 of these 16 patients (56%) central sleep apneas (CSA) occurred (in 8 of these 9 patients in combination with Cheyne-Stokes respiration). Seven of the 16 patients with SRBD (44%) revealed obstructive sleep apneas (OSA). AHI was 32 +/- 15 (12-60) in patients with CSA and 32 +/- 27 (11-86) in patients with OSA. Patients with and without SRBD were comparable concerning left ventricular ejection fraction, NYHA classification, cardiac disease, ICD indication, and concomitant medication. ICD registered ventricular tachyarrhythmias occurred in 10 of 24 patients (42%) without SRBD, in 4 of 9 patients (44%) with CSA, and in 3 of 7 patients (44%) with OSA. The numbers and circadian variation of episodes registered during follow-up in patients without SRBD, with OSA or CSA were comparable (14 +/- 25, median 4 vs 15 +/- 15, median 7 vs 4 +/- 5, median 2.5). The 2-year cardiac mortality was highest in patients with CSA (4/9 (44%) vs. 0/7 patients (0%) with OSA vs 3/24 patients (12.5%) without SRBD. Thus, the prevalence of SRBD in patients with chronic heart failure and a history of malignant ventricular tachyarrhythmias is high (40%) and the occurrence of CSA seems to be predictive for cardiac mortality in these patients. An influence of moderate SRBD on arrhythmia recurrence and circadian variation of spontaneous sustained tachyarrhythmic events could not be demonstrated.  相似文献   
39.
40.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号